CLINICAL_TRIALS
research
· 2026-01-30
Clinical Trial Update: Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD [Phase 2]
Summary
Phase 2 trial of psilocybin-assisted cognitive processing therapy for chronic PTSD is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Unity Health Toronto | Conditions: Post Traumatic Stress Disorder, PTSD | Phase 2 | Status: NOT_YET_RECRUITING